Untitled

International Cooperation DepartmentDIRECTOR Yong-Kwon Kim CONTACT T+82-42-860-4730 F+82-42-860-4739 E-MAIL ykkim@kribb.re.krOpening of World Class Institute (WCI)With the opening of the World Class Institute in December 2009, KRIBB established a global research center for Kinomics-basedanti-cancer development at the Ochang Campus and started joint research. The WCI project, supported by the Ministry ofEducation, Science and Technology, was started to attract leading researchers at home and abroad to conduct joint research,thereby enhancing the global competitiveness of Korean government-funded research institutions.Through the Global Open Innovation networks, 13 domestic and foreign institutions, including Harvard University and MIT, and 22researchers have been conducting joint research to discover Kinomics-based anti-cancer target proteins and drug candidates. Thecenter appointed Dr. Raymond L. Erickson from Harvard University as the head of the organization and conducts research for thediscovery of causal genes and their roles in breast and skin cancers.International Research Project ListPrincipal Investigator at KRIBBProject TitleStartPeriodEndResearch Partner(s)Overseas Research CenterKRIBB operates research cooperation centers on bio-material in the three foothold countries of China, Indonesia, andCosta Rica, and signed an MOU with the University of Kinshasa of Congo in August 2010 to build the Korea-DR Congo BiologicalMaterial Research Center. It has also opened and has been operating the Korea-Hungary Joint Laboratory at the EnzymologyInstitute of the Hungarian Academy of Sciences(HAS) since October 2010, and the Biotechnology Joint Research Center toCombat Desertification at the Institute of Soil and Water Conservation (ISWC) of China and KRIBB as well.Strategic Partnership with Leading Global BusinessesKRIBB is the first institute in Korea to collaborate with Pfizer to conduct joint research to develop optimum therapeutic target genes forliver and stomach cancer. At the same time, it has been developing household product technologies in cooperation with Johnson &Johnson through the discovery and commercialization of potential phytonutrient by utilizing natural extracts.Dr. Bong Hyun Chung Development of materialls for one-spot 2008-07-01 2018-06-30 The University of Kitakyushu,multiple bioanalysisJapanDr. Jihyun F. Kim An Integrated Information Bank for2002-10-01 2011-03-31 Auburn University, USAMicrobial Genome ResearchDr. Jung Hoon Yoon Microbial Resources Bank2002-10-01 2011-03-31 Yanbian University, ChinaDr. Won-Gon Kim Transcriptional regulatory mechanismof development and maintenance ofDopaminergic neurons : Anovel therapeutictarget of Parkinson's Disease2009-01-01 2011-12-31 Harvard University, USADr. Eun Wie Cho Identification of tumor-associated2009-01-01 2011-12-31 The Fred Hutchinson Cancerantibodies/antigens and the development ofcancer diagnosticsResearch Center, USADr.Kyou-Hoon Han The role of pre-structured motifs (PreSMos) 2010-09-01 2013-08-31 Hungarian Academy ofin the promiscuous interactions ofintrinsically unfolded proteinSciences, HungaryDr. Myung Hee Kim Proteome Bank2009-04-01 2011-03-31 University of SouthernCalifornia, USADr.Inpyo Choi Development of platform technology for 2007-06-01 2016-03-31 University of Washington,cancer immunotherapyUSABio-Experts Development Program in BiotechnologyAt the request of the Malaysian government, KRIBB operated a bio-experts development program for Malaysian university biotechnologymajors, who were recommended by the Malaysian government, for two months. As an exemplary cooperation program to enhance thepartnership between Korea and Malaysia in bio-industry, the program was conducted for 8 weeks, focusing on the theory and practice ofbio-industrial process technologies. Ten industrial experts from KRIBB joined the program and 8 students recommended by the Malaysiangovernment completed the course.In June 2010, KRIBB provided training programs for the employees of the Agricultural Research Development Agency (ARDA) of Thailand,on the practical aspects of technology management through Intellectual Property Rights management and micro-organism management.During the same period, at the Vietnam Institute of Ecology and Biological Resources, dignitaries of KRIBB shared Korea’s advancedscience, technology, and experiences through an invitational training session, thereby laying the groundwork for future cooperationbetween the two countries.Dr. Choong-Min Ryu Practical use of induced resistance2007-01-01 2010-12-31 USDA-ARS, USAcompounds derived from endophytic andsoil microorganismsDr.Bo Yeon Kim Global Research Center for Discovery of 2009-12-01 2010-11-30 NIH, USACancer Targets and ChemotherapeuticsBased on Kinomics2009-12-01 2010-11-30 MIT, USA2009-12-01 2010-11-30 Harvard University, USADr.Dae-Yeul Yu Generaion of ENU mutant mice and studies 2005-12-16 2011-02-28 RIKEN, Japanon in vivo function of the miceNanjing University, ChinaDr. Jeong-Heon Ko Institutional cooperation for cancer2006-06-28 2011-06-30 Fred Hutchinson Cancerbiomarker developemntResearch Center, USADr. Jong-Seog Ahn KRIBB-RIKEN Collaboration Research 2006-12-01 2012-08-31 RIKEN, JapanCenter for Chemical BiologyDr. Hyang-Sook Yoo Therapeutic Targets for Liver and Gastric 2009-03-20 2011-03-20 Pfizer, USACancer106 KRIBB Annual Report 2010KRIBB Annual Report 2010 107